| The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer V Tirino, R Camerlingo, R Franco, D Malanga, A La Rocca, G Viglietto, ... European Journal of Cardio-Thoracic Surgery 36 (3), 446-453, 2009 | 332 | 2009 |
| Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung D Malanga, M Scrima, C De Marco, F Fabiani, N De Rosa, S De Gisi, ... Cell cycle 7 (5), 665-669, 2008 | 219 | 2008 |
| Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results P Viola, M Ralli, D Pisani, D Malanga, D Sculco, L Messina, C Laria, ... European Archives of Oto-Rhino-Laryngology 278, 3725-3730, 2021 | 165 | 2021 |
| Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase M Scrima, C De Marco, F Fabiani, R Franco, G Pirozzi, G Rocco, M Ravo, ... PloS one 7 (2), e30427, 2012 | 146 | 2012 |
| Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells G Nassa, A Salvati, R Tarallo, V Gigantino, E Alexandrova, D Memoli, ... Science advances 5 (2), eaav5590, 2019 | 79 | 2019 |
| Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment R Mancini, E Giarnieri, C De Vitis, D Malanga, G Roscilli, A Noto, E Marra, ... PloS one 6 (7), e21320, 2011 | 77 | 2011 |
| Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with … D Malanga, S De Gisi, M Riccardi, M Scrima, C De Marco, M Robledo, ... European Journal of Endocrinology 166 (3), 551-560, 2012 | 68 | 2012 |
| Molecular T-cell repertoire analysis as source of prognostic and predictive biomarkers for checkpoint blockade immunotherapy I Aversa, D Malanga, G Fiume, C Palmieri International journal of molecular sciences 21 (7), 2378, 2020 | 65 | 2020 |
| The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non–small cell lung cancer M Scrima, C De Marco, F De Vita, F Fabiani, R Franco, G Pirozzi, G Rocco, ... The American journal of pathology 180 (3), 1202-1214, 2012 | 64 | 2012 |
| Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells V van den Boom, M Rozenveld-Geugien, F Bonardi, D Malanga, ... Blood, The Journal of the American Society of Hematology 121 (13), 2452-2461, 2013 | 63 | 2013 |
| Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer C De Marco, C Laudanna, N Rinaldo, DM Oliveira, M Ravo, A Weisz, ... PloS one 12 (6), e0178865, 2017 | 62 | 2017 |
| Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis I Aversa, F Zolea, C Ieranò, S Bulotta, AM Trotta, MC Faniello, C De Marco, ... Journal of Experimental & Clinical Cancer Research 36, 1-15, 2017 | 56 | 2017 |
| The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells D Malanga, C De Marco, I Guerriero, F Colelli, N Rinaldo, M Scrima, ... Oncotarget 6 (40), 42667, 2015 | 51 | 2015 |
| Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer G Chiappetta, C De Marco, A Quintiero, D Califano, S Gherardi, ... Endocrine-Related Cancer 14 (2), 405-420, 2007 | 49 | 2007 |
| Allelic variant at− 79 (C> T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels I Landa, C Montero-Conde, D Malanga, S De Gisi, G Pita, ... Endocrine-Related Cancer 17 (2), 317-328, 2010 | 46 | 2010 |
| Contribution of PKB/AKT signaling to thyroid cancer. G Viglietto, N Amodio, D Malanga, M Scrima, C De Marco Frontiers in Bioscience (Landmark Edition) 16 (4), 1461-1487, 2011 | 41 | 2011 |
| Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells I Guerriero, D D’Angelo, P Pallante, M Santos, M Scrima, D Malanga, ... Oncotarget 8 (12), 19172, 2017 | 40 | 2017 |
| Loss of p27 expression through RAS-> BRAF-> MAP kinase-dependent pathway in human thyroid carcinomas ML Motti, C De Marco, D Califano, S De Gisi, D Malanga, G Troncone, ... Cell cycle 6 (22), 2817-2825, 2007 | 36 | 2007 |
| PKC-dependent phosphorylation of p27 at T198 contributes to p27 stabilization and cell cycle arrest F De Vita, M Riccardi, D Malanga, M Scrima, C De Marco, G Viglietto Cell cycle 11 (8), 1583-1592, 2012 | 33 | 2012 |
| Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto … D Mendes Oliveira, K Grillone, C Mignogna, V De Falco, C Laudanna, ... Journal of Experimental & Clinical Cancer Research 37, 1-12, 2018 | 31 | 2018 |
